About Us
Introduction
Organization Setup
Contact Details
Message
Pharmaceutical Industry in Gujarat

FOOD AND DRUGS CONTROL ADMINISTRATION, GUJARAT STATE

INTRODUCTION

One of the most important event in the annals of India was the bifurcation of the erstwhile Bombay State into Gujarat and Maharashtra in the year 1960. People welcomed the new State with crackers, musical rhythms combined with Dandiya Ras with great joy and enthusiasm, welcoming a new era. Gujarat with its meager capacity of manpower started its administration with the capital at Ahmedabad. However, progress in industry coupled with increase in population, traffic etc. made our genius administrators  shift the capital from Ahmedabad to Gandhinagar on May 1, 1970. Dr. Jivraj Mehta was the first Chief Minister of Gujarat, representing the Congress political party and Mr. Narendra Modi is the present Chief Minister representing the Bharathiya Janata Party of Gujarat State.

Initially, the Department was known as Drugs Control Administration having its office at Civil Hospital Compound, Asarwa, Ahmedabad headed by Director. Dr. B.V. Patel. an eminent personality in the field of Pharmacy and the first Director. The Drugs Control Administration office shifted to Apana Bazar, Lal Darwaja, Ahmedabad due to some administrative difficulties. With the increase in number of Pharmaceutical industrial units, increase in staff, work and administrative problems compelled the shift of the office to Gandhinagar in 1984 having its office at Dr. Jivraj Mehta Bhavan, Block No. 8, 1st Floor, Sachivalaya, Tel. No. 079-3220176, 079-3221170, Tel. Fax - 079-21170.

Mr. Subodh P. Adeshara, M.Pham is the present Commissioner. He is young energetic, active and an eminent Administrator. His pleasant and smiling face and his knowledge in Pharmacy field acclaimed him as one of the able Administrator and an excellent Orator. He has been honored by the DIWA AWARD - 2002- meant for the meritorious services rendered in Pharmacy Profession, (Drugs Inspectors Welfare Association) to commemorate his effective and efficient services in the field of Pharmacy. His active role in Central Government in day to day amendments to Drugs & Cosmetics Act and its Allied Acts, Prevention of Food Adulteration Act, cannot be emphasized in one or two words. His role in Central Government is to work either as a Chairman or a Member of the following Committees constituted by the Central Government.


Sr.No. Name of the Committee Designation Purpose/Function of the Committee
1. Indian Pharmacopoeia Committee Member Additional/deletion/addendum related to Indian Pharmacopoeia.
2. Drug Technical Advisory Committee Member Recommendation for addition/deletion if any, in drug formulation, bulk drugs etc.
3. Gradation of the Penalities for Offences under D&C Act. Member Recommendations for insertion/amendment/deletion in D&C Act for the offences.
4. Central Committee for Food Standards Member Recommendations to be made for amendment/insertion/deletion in PFA Act.
5. Sub-Committee for Legal Issues under PFA. Chairman The Committee recommends the problems and prospects of Legal issues involved in administration of PFA Act.
6. Subcommittee for Inclusion of Additional Blood Components. Member Subcommittee to recommend for inclusion of Monograph of certain additional Blood Components and Blood Products.
7. Subcommittee on WHO GMP Certification Scheme Member To recommend the procedures to be followed by the manufacturers for obtaining WHO GMP Certificate.
8. Subcommittee on GMP to be followed by Food Industries Member The Subcommittee recommends the procedures to be followed by the Food Industries for Good Manufacturing Practices.
9. Western Zone-Zonal Committee under NPPA Chairman Identification and Elimination of spurious drugs
10. Subcommittee under National Pharmaceutical Pricing Authority Member To study of Norms of CC, PC, and PL.
11. Expert Committee Under I.P Member Norms to be fixed for LVP containers.
12. Subcommittee of Drugs Consultative Committee Chairman To recommend the increase in License Fees
13. Steering Committee Member Reg. Issue of claims on Cosmetic products.
14. Subcommittee CCFS Member Review the composition of Food Laws and Legal Advice.
15. Subcommittee of DCC on Oxytocin Member Consideration of banning of Oxytocin Injection.
16. Expert standing Committee of DCC Chairman Amendment of Rule 85(2) - Power of Licensing Authority cannot be challenged by the Appellate Authority or the Court.
17. Subcommittee of DCC Member Reg. Feed Supplement
18. Committee Framed by DCG(I) Member Study and report on the Spurious drugs mfgd. and sold in the Indian Market.
19. BV Patel PERD Centre Member R&D of the Institute.
20. IDMA, Gujarat State Member Evaluation and reporting of the problems of Members
21. State Drug Policy. Chairman To frame Drug Policy for the State.
22. Sub-Committee of CCFS Member Reg. Food Laws and Legal Advise.
23. Western Zonal Committee Chairman Identification and Elimination of Spurious drugs.
24.. Subcommittee of DTAB Member Fixed Does Combination of Drugs.
25. Pharmacy Council of India Member Suggestions/corrections/opinion etc. on Pharmacy Acts.
26. Drugs Consultative Committee Member Expert opinion and suggestions on formulations.
27. Subcommittee under DCC Member Manufacture of LVPs under loan license.
28. Subcommittee under DCC member Inclusion of Medical Devices under Drugs
29. Subcommittee under DCC Member Inclusion of Surgical Dressings under Drugs.
30. Central Medical Stores Member Purchase of Medicines to Govt. Hospitals.
31. Subcommittee under DCC Member To examine and to recommend OTC Drugs.
32. Committee under DGHS Member To recommend drug formulary.
33. Sub Committee under DCC Chairman To examine and to recommend implementation of Rule 64.
34. Sub Committee under DCC Chairman To examine Erythromycin formulation, bulk drugs etc.
35 Sub Committee under DCC Chairman To examine the recommendation of sub-committee on Good Laboratory Practices.
Conceptualised By : SilverTouch Computers Pvt. Ltd, Ahemedabad, India
Health and Family Welfare Department All Right Reserved. Terms of use | Privacy statement | Accessibility